We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 295 results
  1. Hyperglucagonaemia in diabetes: altered amino acid metabolism triggers mTORC1 activation, which drives glucagon production

    Aim/hypothesis

    Hyperglycaemia is associated with alpha cell dysfunction, leading to dysregulated glucagon secretion in type 1 and type 2 diabetes;...

    Yael Riahi, Aviram Kogot-Levin, ... Gil Leibowitz in Diabetologia
    Article 22 July 2023
  2. 100 years of glucagon and 100 more

    The peptide hormone glucagon, discovered in late 1922, is secreted from pancreatic alpha cells and is an essential regulator of metabolic...

    Nicolai J. Wewer Albrechtsen, Jens J. Holst, ... Timo D. Müller in Diabetologia
    Article 27 June 2023
  3. Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation

    Aims/hypothesis

    Type 2 diabetes is characterised by hyperglucagonaemia and perturbed function of pancreatic glucagon-secreting alpha cells but the...

    Beatriz Merino, Elena Casanueva-Álvarez, ... Irene Cózar-Castellano in Diabetologia
    Article Open access 02 June 2022
  4. Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases

    Insulin and glucagon exert opposing effects on glucose metabolism and, consequently, pancreatic islet β-cells and α-cells are considered functional...

    Sofie Hædersdal, Andreas Andersen, ... Tina Vilsbøll in Nature Reviews Endocrinology
    Article 17 March 2023
  5. Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study

    Aims/hypotheses

    Glucagon and glucagon-like peptide-1 (GLP-1) are derived from the same precursor; proglucagon, and dual agonists of their receptors...

    Marie Winther-Sørensen, Sara L. Garcia, ... Nicolai J. Wewer Albrechtsen in Diabetologia
    Article Open access 06 May 2024
  6. The liver–alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels

    Aims/hypothesis

    Many individuals who develop type 2 diabetes also display increased glucagon levels (hyperglucagonaemia), which we have previously...

    Christina Gar, Stefanie J. Haschka, ... Andreas Lechner in Diabetologia
    Article Open access 04 December 2020
  7. Up Front

    Article 21 June 2022
  8. Where to for precision treatment of HNF1A-MODY?

    Caroline Bonner, Chiara Saponaro in Diabetologia
    Article 12 April 2022
  9. Hepatic glucose metabolism in the steatotic liver

    The liver is central in regulating glucose homeostasis, being the major contributor to endogenous glucose production and the greatest reserve of...

    Egeria Scoditti, Silvia Sabatini, ... Amalia Gastaldelli in Nature Reviews Gastroenterology & Hepatology
    Article 02 February 2024
  10. Upregulated TGF-β1 contributes to hyperglycaemia in type 2 diabetes by potentiating glucagon signalling

    Aims/hypothesis

    Glucagon-stimulated hepatic gluconeogenesis contributes to endogenous glucose production during fasting. Recent studies suggest that...

    Yang **ao, Yanfei Wang, ... Lily Q. Dong in Diabetologia
    Article 14 March 2023
  11. Up Front

    Article 28 June 2023
  12. Up Front

    Article 24 August 2023
  13. Glucagon receptor antagonists might stimulate β-cell expansion

    Maria F. Rubin de Celis, Susan Bonner-Weir in Nature Reviews Endocrinology
    Article 15 August 2022
  14. Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia

    Aims/hypothesis

    Repeated exposures to insulin-induced hypoglycaemia in people with diabetes progressively impairs the counterregulatory response (CRR)...

    Judit Castillo-Armengol, Flavia Marzetta, ... Bernard Thorens in Diabetologia
    Article Open access 28 November 2023
  15. Mammalian models of diabetes mellitus, with a focus on type 2 diabetes mellitus

    Although no single animal model replicates all aspects of diabetes mellitus in humans, animal models are essential for the study of energy balance...

    Thomas A. Lutz in Nature Reviews Endocrinology
    Article 20 March 2023
  16. A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY

    Aims/hypothesis

    Systematic studies on the phenotypic consequences of variants causal of HNF1A-MODY are rare. Our aim was to assess the phenotype of...

    Jarno L. T. Kettunen, Elina Rantala, ... Tiinamaija Tuomi in Diabetologia
    Article Open access 24 December 2021
  17. Non-invasive imaging of sympathetic innervation of the pancreas in individuals with type 2 diabetes

    Aims/hypothesis

    Compromised pancreatic sympathetic innervation has been suggested as a factor involved in both immune-mediated beta cell destruction...

    Achyut Ram Vyakaranam, Maryama M. Mahamed, ... Anders Sundin in Diabetologia
    Article Open access 07 November 2023
Did you find what you were looking for? Share feedback.